21 U.S.C. § 360aaa-6
Section 360aaa-6 · Rules of construction
Amended 2 times on record
Nothing in section 360aaa of this title shall be construed as prohibiting a manufacturer from disseminating information in response to an unsolicited request from a health care practitioner.
Notwithstanding subsection (a), (f), or (o) of section 352 of this title, or any other provision of law, the dissemination of information relating to a new use of a drug or device, in accordance with section 360aaa of this title, shall not be construed by the Secretary as evidence of a new intended use of the drug or device that is different from the intended use of the drug or device set forth in the official labeling of the drug or device. Such dissemination shall not be considered by the Secretary as labeling, adulteration, or misbranding of the drug or device.
Nothing in section 360aaa of this title shall affect patent rights in any manner.
Nothing in section 360aaa of this title shall be construed as prohibiting an entity that publishes a scientific journal (as defined in section 360aaa–5(5) of this title) from requiring authorization from the entity to disseminate an article published by such entity or charging fees for the purchase of reprints of published articles from such entity.
Editorial notes U.S. Code · Office of the Law Revision Counsel
Termination of Section
For termination of section by section 401(e) of Pub. L. 105–115, see Effective and Termination Dates note set out under section 360aaa of this title.